These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Massachusetts
|
06-0513860
|
|
(State or other jurisdiction of
|
(I. R. S. Employer Identification No.)
|
|
incorporation or organization)
|
|
|
|
|
|
P.O. Box 188, One Technology Drive, Rogers, Connecticut
|
06263-0188
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
ý
|
Accelerated filer
o
|
|
|
Non-accelerated filer
o
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
|
|
Emerging growth company
o
|
|
TABLE OF CONTENTS
|
|||
|
Part I – Financial Information
|
|||
|
|
|
|
|
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|||
|
|
|||
|
|
|||
|
Part II – Other Information
|
|||
|
|
|
||
|
|
|||
|
|
|
|
|
|
Item 1.
|
Financial Statements
|
|
|
Quarter Ended
|
||||||
|
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
$
|
203,828
|
|
|
$
|
160,566
|
|
|
Cost of sales
|
123,478
|
|
|
100,058
|
|
||
|
Gross margin
|
80,350
|
|
|
60,508
|
|
||
|
|
|
|
|
|
|||
|
Selling, general and administrative expenses
|
34,165
|
|
|
29,860
|
|
||
|
Research and development expenses
|
6,961
|
|
|
6,549
|
|
||
|
Restructuring and impairment charges
|
725
|
|
|
—
|
|
||
|
Gain on sale of long-lived asset
|
(942
|
)
|
|
—
|
|
||
|
Operating income
|
39,441
|
|
|
24,099
|
|
||
|
|
|
|
|
||||
|
Equity income in unconsolidated joint ventures
|
1,009
|
|
|
613
|
|
||
|
Other income (expense), net
|
715
|
|
|
(546
|
)
|
||
|
Interest expense, net
|
(1,248
|
)
|
|
(1,121
|
)
|
||
|
Income before income tax expense
|
39,917
|
|
|
23,045
|
|
||
|
Income tax expense
|
12,885
|
|
|
8,117
|
|
||
|
Net income
|
$
|
27,032
|
|
|
$
|
14,928
|
|
|
|
|
|
|
||||
|
Basic earnings per share
|
$
|
1.50
|
|
|
$
|
0.83
|
|
|
Diluted earnings per share
|
$
|
1.47
|
|
|
$
|
0.82
|
|
|
|
|
|
|
||||
|
Shares used in computing:
|
|
|
|
|
|
||
|
Basic earnings per share
|
18,056
|
|
|
17,966
|
|
||
|
Diluted earnings per share
|
18,373
|
|
|
18,214
|
|
||
|
|
Quarter Ended
|
||||||
|
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net income
|
$
|
27,032
|
|
|
$
|
14,928
|
|
|
|
|
|
|
||||
|
Foreign currency translation adjustment
|
4,138
|
|
|
10,926
|
|
||
|
Derivative instruments designated as cash flow hedges:
|
|
|
|
||||
|
Unrealized gain (loss) on derivative instruments held at period end, net of tax (Note 6)
|
(114
|
)
|
|
4
|
|
||
|
Unrealized gain (loss) reclassified into earnings (Note 6)
|
—
|
|
|
2
|
|
||
|
Pension and postretirement benefit plans reclassified into earnings, net of tax (Note 6):
|
|
|
|
||||
|
Amortization of loss
|
30
|
|
|
35
|
|
||
|
Other comprehensive income (loss)
|
4,054
|
|
|
10,967
|
|
||
|
|
|
|
|
||||
|
Comprehensive income (loss)
|
$
|
31,086
|
|
|
$
|
25,895
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Assets
|
|
|
|
||||
|
Current assets
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
186,111
|
|
|
$
|
227,767
|
|
|
Accounts receivable, less allowance for doubtful accounts of $2,336 and $1,952
|
134,084
|
|
|
119,604
|
|
||
|
Inventories
|
94,795
|
|
|
91,130
|
|
||
|
Prepaid income taxes
|
3,924
|
|
|
3,020
|
|
||
|
Asbestos-related insurance receivables
|
7,099
|
|
|
7,099
|
|
||
|
Other current assets
|
12,616
|
|
|
8,910
|
|
||
|
Assets held for sale
|
1,727
|
|
|
871
|
|
||
|
Total current assets
|
440,356
|
|
|
458,401
|
|
||
|
|
|
|
|
||||
|
Property, plant and equipment, net of accumulated depreciation
|
175,642
|
|
|
176,916
|
|
||
|
Investments in unconsolidated joint ventures
|
16,726
|
|
|
16,183
|
|
||
|
Deferred income taxes
|
23,480
|
|
|
14,634
|
|
||
|
Goodwill
|
228,229
|
|
|
208,431
|
|
||
|
Other intangible assets
|
169,579
|
|
|
136,676
|
|
||
|
Asbestos-related insurance receivables
|
41,295
|
|
|
41,295
|
|
||
|
Other long-term assets
|
6,081
|
|
|
3,964
|
|
||
|
Total assets
|
$
|
1,101,388
|
|
|
$
|
1,056,500
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
|
|
||
|
Current liabilities
|
|
|
|
|
|
||
|
Accounts payable
|
$
|
30,297
|
|
|
$
|
28,379
|
|
|
Accrued employee benefits and compensation
|
24,696
|
|
|
31,104
|
|
||
|
Accrued income taxes payable
|
15,506
|
|
|
10,921
|
|
||
|
Current portion of lease obligation
|
356
|
|
|
350
|
|
||
|
Current portion of long term debt
|
—
|
|
|
3,653
|
|
||
|
Asbestos-related liabilities
|
7,099
|
|
|
7,099
|
|
||
|
Other accrued liabilities
|
19,162
|
|
|
19,679
|
|
||
|
Total current liabilities
|
97,116
|
|
|
101,185
|
|
||
|
Borrowings under credit facility
|
241,188
|
|
|
235,877
|
|
||
|
Long term lease obligation
|
4,962
|
|
|
4,993
|
|
||
|
Pension and post-retirement benefit obligations
|
8,501
|
|
|
8,501
|
|
||
|
Retiree health care and life insurance benefits
|
1,992
|
|
|
1,992
|
|
||
|
Asbestos-related liabilities
|
44,883
|
|
|
44,883
|
|
||
|
Non-current income tax
|
6,517
|
|
|
6,238
|
|
||
|
Deferred income taxes
|
13,463
|
|
|
13,883
|
|
||
|
Other long-term liabilities
|
3,527
|
|
|
3,162
|
|
||
|
Commitments and Contingencies (Note 14)
|
|
|
|
|
|
||
|
Shareholders’ Equity
|
|
|
|
|
|
||
|
Capital Stock - $1 par value; 50,000 authorized shares; 18,121 and 18,021 shares outstanding
|
18,121
|
|
|
18,021
|
|
||
|
Additional paid-in capital
|
118,213
|
|
|
118,678
|
|
||
|
Retained earnings
|
631,113
|
|
|
591,349
|
|
||
|
Accumulated other comprehensive income (loss)
|
(88,208
|
)
|
|
(92,262
|
)
|
||
|
Total shareholders’ equity
|
679,239
|
|
|
635,786
|
|
||
|
Total liabilities and shareholders’ equity
|
$
|
1,101,388
|
|
|
$
|
1,056,500
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Operating Activities:
|
|
|
|
||||
|
Net income
|
$
|
27,032
|
|
|
$
|
14,928
|
|
|
Adjustments to reconcile net income to cash from operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
10,547
|
|
|
8,973
|
|
||
|
Stock-based compensation expense
|
1,020
|
|
|
1,992
|
|
||
|
Deferred income taxes
|
3,516
|
|
|
1,013
|
|
||
|
Equity in undistributed income of unconsolidated joint ventures
|
(1,009
|
)
|
|
(613
|
)
|
||
|
Dividends received from unconsolidated joint ventures
|
616
|
|
|
—
|
|
||
|
Pension and postretirement benefits
|
(365
|
)
|
|
(702
|
)
|
||
|
Loss (gain) from the sale of property, plant and equipment
|
(947
|
)
|
|
—
|
|
||
|
Bad debt expense
|
384
|
|
|
—
|
|
||
|
Proceeds from insurance related to operations
|
480
|
|
|
—
|
|
||
|
Changes in operating assets and liabilities, excluding effects of acquisitions:
|
|
|
|
|
|
||
|
Accounts receivable
|
(12,439
|
)
|
|
(6,657
|
)
|
||
|
Inventories
|
(769
|
)
|
|
(1,021
|
)
|
||
|
Pension contribution
|
(70
|
)
|
|
(63
|
)
|
||
|
Other current assets
|
(4,063
|
)
|
|
(1,621
|
)
|
||
|
Accounts payable and other accrued expenses
|
(1,441
|
)
|
|
8,307
|
|
||
|
Other, net
|
742
|
|
|
1,651
|
|
||
|
Net cash provided by operating activities
|
23,234
|
|
|
26,187
|
|
||
|
|
|
|
|
||||
|
Investing Activities:
|
|
|
|
|
|
||
|
Business acquisition
|
(60,191
|
)
|
|
—
|
|
||
|
Capital expenditures, net
|
(5,270
|
)
|
|
(4,813
|
)
|
||
|
Proceeds from insurance related to property, plant and equipment
|
450
|
|
|
—
|
|
||
|
Proceeds from the sale of property, plant and equipment, net
|
1,603
|
|
|
—
|
|
||
|
Net cash used in investing activities
|
(63,408
|
)
|
|
(4,813
|
)
|
||
|
|
|
|
|
||||
|
Financing Activities:
|
|
|
|
|
|
||
|
Proceeds from long term borrowings
|
—
|
|
|
—
|
|
||
|
Debt issuance costs
|
(1,029
|
)
|
|
—
|
|
||
|
Repayment of debt principal and long term lease obligation
|
(87
|
)
|
|
(757
|
)
|
||
|
Repurchases of capital stock
|
—
|
|
|
(1,997
|
)
|
||
|
Proceeds from the exercise of stock options, net
|
765
|
|
|
564
|
|
||
|
Issuance of shares upon vesting of restricted stock units, net
|
(2,572
|
)
|
|
(1,175
|
)
|
||
|
Proceeds from issuance of shares to employee stock purchase plan
|
422
|
|
|
427
|
|
||
|
Net cash (used in) provided by financing activities
|
(2,501
|
)
|
|
(2,938
|
)
|
||
|
|
|
|
|
||||
|
Effect of exchange rate fluctuations on cash
|
1,019
|
|
|
6,181
|
|
||
|
|
|
|
|
||||
|
Net increase (decrease) in cash and cash equivalents
|
(41,656
|
)
|
|
24,617
|
|
||
|
Cash and cash equivalents at beginning of period
|
227,767
|
|
|
204,586
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
186,111
|
|
|
$
|
229,203
|
|
|
|
Capital Stock/Capital Shares
|
|
Additional Paid-In Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Loss
|
|
Total Shareholders’ Equity
|
||||||||||
|
Balance at December 31, 2016
|
$
|
18,021
|
|
|
$
|
118,678
|
|
|
$
|
591,349
|
|
|
$
|
(92,262
|
)
|
|
$
|
635,786
|
|
|
Net income
|
—
|
|
|
—
|
|
|
27,032
|
|
|
—
|
|
|
27,032
|
|
|||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
4,054
|
|
|
4,054
|
|
|||||
|
Stock options exercised
|
22
|
|
|
743
|
|
|
—
|
|
|
—
|
|
|
765
|
|
|||||
|
Shares issued for employees stock purchase plan
|
8
|
|
|
414
|
|
|
—
|
|
|
—
|
|
|
422
|
|
|||||
|
Shares issued for vested restricted stock units, net of cancellations for tax withholding
|
70
|
|
|
(2,642
|
)
|
|
—
|
|
|
—
|
|
|
(2,572
|
)
|
|||||
|
Cumulative-effect adjustment of change in accounting for share-based compensation
|
—
|
|
|
—
|
|
|
12,732
|
|
|
—
|
|
|
12,732
|
|
|||||
|
Stock-based compensation expense
|
—
|
|
|
1,020
|
|
|
—
|
|
|
—
|
|
|
1,020
|
|
|||||
|
Balance at March 31, 2017
|
$
|
18,121
|
|
|
$
|
118,213
|
|
|
$
|
631,113
|
|
|
$
|
(88,208
|
)
|
|
$
|
679,239
|
|
|
•
|
Level 1 – Quoted prices in active markets for identical assets or liabilities.
|
|
•
|
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
|
|
•
|
Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
|
(Dollars in thousands)
|
|
Carrying amount as of March 31, 2017
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Foreign currency contracts
|
|
$
|
21
|
|
|
$
|
—
|
|
|
$
|
21
|
|
|
$
|
—
|
|
|
Copper derivative contracts
|
|
$
|
1,342
|
|
|
$
|
—
|
|
|
$
|
1,342
|
|
|
$
|
—
|
|
|
Interest rate swap
|
|
$
|
(180
|
)
|
|
$
|
—
|
|
|
$
|
(180
|
)
|
|
$
|
—
|
|
|
(Dollars in thousands)
|
|
Carrying amount as of December 31, 2016
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Foreign currency contracts
|
|
$
|
(170
|
)
|
|
$
|
—
|
|
|
$
|
(170
|
)
|
|
$
|
—
|
|
|
Copper derivative contracts
|
|
$
|
1,277
|
|
|
$
|
—
|
|
|
$
|
1,277
|
|
|
$
|
—
|
|
|
•
|
Foreign Currency
- The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.
|
|
•
|
Commodity -
The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates the constant changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date. Overall, fair value is a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate, and volatility.
|
|
•
|
Interest Rates
- The fair value of interest rate swap instruments is derived by comparing the present value of the interest rate forward curve against the present value of the swap rate, relative to the notional amount of the swap. The net value represents the estimated amount we would receive or pay to terminate the agreements. Settlement amounts for an “in the money” swap would be adjusted down to compensate the counterparty for cost of funds, and the adjustment is directly related to the counterparties’ credit ratings.
|
|
Notional Values of Foreign Currency Derivatives
|
||||
|
KRW/USD
|
|
₩
|
5,291,766,000
|
|
|
USD/JPY
|
|
$
|
512,637
|
|
|
JPY/EUR
|
|
¥
|
338,000,000
|
|
|
EUR/USD
|
|
€
|
3,914,930
|
|
|
EUR/HUF
|
|
€
|
586,678
|
|
|
USD/CNY
|
|
$
|
6,083,500
|
|
|
Notional Value of Copper Derivatives
|
||
|
April 2017 - June 2017
|
122
|
metric tons per month
|
|
July 2017 - September 2017
|
122
|
metric tons per month
|
|
October 2017 - December 2017
|
122
|
metric tons per month
|
|
January 2018 - March 2018
|
56
|
metric tons per month
|
|
April 2018 - June 2018
|
25
|
metric tons per month
|
|
(Dollars in thousands)
|
|
|
|
The Effect of Current Derivative Instruments on the Financial Statements for the period ended March 31, 2017
|
Fair Values of Derivative Instruments as of March 31, 2017
|
||||
|
|
|
|
|
Gain (Loss)
|
Other Assets (Liabilities)
|
||||
|
Foreign Exchange Contracts
|
|
Location
|
|
|
|
||||
|
Contracts not designated as hedging instruments
|
|
Other income (expense), net
|
|
$
|
21
|
|
$
|
21
|
|
|
Copper Derivatives
|
|
|
|
|
|
||||
|
Contracts not designated as hedging instruments
|
|
Other income (expense), net
|
|
$
|
215
|
|
$
|
1,342
|
|
|
Interest Rate Swap
|
|
|
|
|
|
||||
|
Contract designated as hedging instrument
|
|
Other comprehensive income (loss)
|
|
$
|
(180
|
)
|
$
|
(180
|
)
|
|
(Dollars in thousands)
|
|
|
|
The Effect of Current Derivative Instruments on the Financial Statements for the period ended March 31, 2016
|
Fair Values of Derivative Instruments as of March 31, 2016
|
||||
|
|
|
|
|
Gain (Loss)
|
Other Assets (Liabilities)
|
||||
|
Foreign Exchange Contracts
|
|
Location
|
|
|
|
||||
|
Contracts not designated as hedging instruments
|
|
Other income (expense), net
|
|
$
|
(114
|
)
|
$
|
(114
|
)
|
|
Copper Derivatives
|
|
|
|
|
|
||||
|
Contracts not designated as hedging instruments
|
|
Other income (expense), net
|
|
$
|
33
|
|
$
|
255
|
|
|
Interest Rate Swap
|
|
|
|
|
|
||||
|
Contracts designated as hedging instruments
|
|
Other comprehensive income (loss)
|
|
$
|
11
|
|
$
|
(7
|
)
|
|
(Dollars in thousands)
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Raw materials
|
$
|
33,850
|
|
|
$
|
29,788
|
|
|
Work-in-process
|
26,452
|
|
|
26,440
|
|
||
|
Finished goods
|
34,493
|
|
|
34,902
|
|
||
|
Total inventories
|
$
|
94,795
|
|
|
$
|
91,130
|
|
|
(Dollars in thousands)
|
January 6, 2017
|
||
|
Assets:
|
|
||
|
Accounts receivable
|
$
|
2,724
|
|
|
Prepaid expenses
|
21
|
|
|
|
Inventory
|
2,433
|
|
|
|
Property, plant & equipment
|
1,589
|
|
|
|
Intangible assets
|
35,860
|
|
|
|
Goodwill
|
17,793
|
|
|
|
Total assets
|
60,420
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
Accounts payable
|
179
|
|
|
|
Accrued expenses
|
50
|
|
|
|
Total liabilities
|
229
|
|
|
|
|
|
|
|
|
Fair value of net assets acquired
|
$
|
60,191
|
|
|
(Dollars in thousands)
|
November 23, 2016
|
||
|
Assets:
|
|
||
|
Cash and cash equivalents
|
$
|
1,539
|
|
|
Accounts receivable
|
7,513
|
|
|
|
Other current assets
|
691
|
|
|
|
Inventory
|
9,915
|
|
|
|
Property, plant & equipment
|
9,932
|
|
|
|
Intangible assets
|
73,500
|
|
|
|
Goodwill
|
35,755
|
|
|
|
Other long-term assets
|
101
|
|
|
|
Total assets
|
138,946
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
Accounts payable
|
2,402
|
|
|
|
Other current liabilities
|
1,062
|
|
|
|
Total liabilities
|
3,464
|
|
|
|
|
|
|
|
|
Fair value of net assets acquired
|
$
|
135,482
|
|
|
(Dollars in thousands)
|
Three months ended March 31, 2016
|
||
|
Net sales
|
$
|
178,897
|
|
|
Net income
|
13,263
|
|
|
|
(Dollars in thousands)
|
Foreign currency translation adjustments
|
|
Funded status of pension plans and other postretirement benefits (1)
|
|
Unrealized gain (loss) on derivative instruments (2)
|
|
Total
|
||||||||
|
Beginning Balance December 31, 2015
|
$
|
(41,365
|
)
|
|
$
|
(47,082
|
)
|
|
$
|
(11
|
)
|
|
$
|
(88,458
|
)
|
|
Other comprehensive income (loss) before reclassifications
|
10,926
|
|
|
—
|
|
|
4
|
|
|
10,930
|
|
||||
|
Amounts reclassified from accumulated other comprehensive income (loss) (3)
|
—
|
|
|
35
|
|
|
2
|
|
|
37
|
|
||||
|
Net current-period other comprehensive income (loss)
|
10,926
|
|
|
35
|
|
|
6
|
|
|
10,967
|
|
||||
|
Ending Balance March 31, 2016
|
$
|
(30,439
|
)
|
|
$
|
(47,047
|
)
|
|
$
|
(5
|
)
|
|
$
|
(77,491
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Beginning Balance December 31, 2016
|
$
|
(46,446
|
)
|
|
$
|
(45,816
|
)
|
|
$
|
—
|
|
|
$
|
(92,262
|
)
|
|
Other comprehensive income (loss) before reclassifications
|
4,138
|
|
|
—
|
|
|
(114
|
)
|
|
4,024
|
|
||||
|
Amounts reclassified from accumulated other comprehensive income (loss) (4)
|
—
|
|
|
30
|
|
|
—
|
|
|
30
|
|
||||
|
Net current-period other comprehensive income (loss)
|
4,138
|
|
|
30
|
|
|
(114
|
)
|
|
4,054
|
|
||||
|
Ending Balance March 31, 2017
|
$
|
(42,308
|
)
|
|
$
|
(45,786
|
)
|
|
$
|
(114
|
)
|
|
$
|
(88,208
|
)
|
|
(In thousands, except per share amounts)
|
Quarter Ended
|
||||||
|
March 31, 2017
|
|
March 31, 2016
|
|||||
|
Numerator:
|
|
|
|
||||
|
Net income
|
$
|
27,032
|
|
|
$
|
14,928
|
|
|
Denominator:
|
|
|
|
||||
|
Weighted-average shares outstanding - basic
|
18,056
|
|
|
17,966
|
|
||
|
Effect of dilutive shares
|
317
|
|
|
248
|
|
||
|
Weighted-average shares outstanding - diluted
|
18,373
|
|
|
18,214
|
|
||
|
Basic earnings per share
|
$
|
1.50
|
|
|
$
|
0.83
|
|
|
Diluted earnings per share
|
$
|
1.47
|
|
|
$
|
0.82
|
|
|
|
|
March 31,
2017 |
|
March 31,
2016 |
|
Expected volatility
|
|
33.6%
|
|
29.6%
|
|
Expected term (in years)
|
|
3.0
|
|
3.0
|
|
Risk-free interest rate
|
|
1.38%
|
|
0.93%
|
|
|
Performance-Based Restricted Stock Awards
|
|
|
Non-vested awards outstanding at December 31, 2016
|
151,769
|
|
|
Awards granted
|
56,147
|
|
|
Stock issued
|
(33,887
|
)
|
|
Awards forfeited
|
(3,205
|
)
|
|
Non-vested awards outstanding at March 31, 2017
|
170,824
|
|
|
|
Time-Based Restricted Stock Awards
|
|
|
Non-vested awards outstanding at December 31, 2016
|
239,189
|
|
|
Awards granted
|
75,710
|
|
|
Stock issued
|
(67,183
|
)
|
|
Awards forfeited
|
(4,385
|
)
|
|
Non-vested awards outstanding at March 31, 2017
|
243,331
|
|
|
|
Deferred Stock
Units
|
|
|
Awards outstanding at December 31, 2016
|
11,900
|
|
|
Awards granted
|
—
|
|
|
Stock issued
|
—
|
|
|
Awards outstanding at March 31, 2017
|
11,900
|
|
|
|
Options Outstanding
|
|
Weighted- Average Exercise Price Per Share
|
|
Weighted-Average Remaining Contractual Life in Years
|
|
Aggregate Intrinsic Value
|
|||||
|
Options outstanding at December 31, 2016
|
116,575
|
|
|
$
|
37.76
|
|
|
3.2
|
|
$
|
4,552,580
|
|
|
Options exercised
|
(22,300
|
)
|
|
$
|
34.30
|
|
|
|
|
|
|
|
|
Options forfeited
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
Options outstanding at March 31, 2017
|
94,275
|
|
|
$
|
37.46
|
|
|
3.1
|
|
$
|
4,563,655
|
|
|
Options exercisable at March 31, 2017
|
94,275
|
|
|
$
|
37.46
|
|
|
3.1
|
|
$
|
4,563,655
|
|
|
Options vested at March 31, 2017
|
94,275
|
|
|
$
|
37.46
|
|
|
3.1
|
|
$
|
4,563,655
|
|
|
(Dollars in thousands)
|
Pension Benefits
|
|
Retirement Health and Life Insurance Benefits
|
||||||||||||
|
Quarter Ended
|
|
Quarter Ended
|
|||||||||||||
|
Change in benefit obligation:
|
March 31, 2017
|
|
March 31, 2016
|
|
March 31, 2017
|
|
March 31, 2016
|
||||||||
|
Service cost
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
39
|
|
|
$
|
37
|
|
|
Interest cost
|
1,841
|
|
|
1,893
|
|
|
18
|
|
|
19
|
|
||||
|
Expected return on plan assets
|
(2,309
|
)
|
|
(2,706
|
)
|
|
—
|
|
|
—
|
|
||||
|
Amortization of prior service cost (credit)
|
—
|
|
|
—
|
|
|
(373
|
)
|
|
(373
|
)
|
||||
|
Amortization of net loss (gain)
|
433
|
|
|
447
|
|
|
(14
|
)
|
|
(19
|
)
|
||||
|
Net periodic (benefit) cost
|
$
|
(35
|
)
|
|
$
|
(366
|
)
|
|
$
|
(330
|
)
|
|
$
|
(336
|
)
|
|
|
Quarter Ended
|
||||||
|
(Dollars in thousands)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
|
|
|
||||
|
Advanced Connectivity Solutions
|
$
|
78,543
|
|
|
$
|
73,376
|
|
|
Elastomeric Material Solutions
|
76,849
|
|
|
46,317
|
|
||
|
Power Electronics Solutions
|
42,651
|
|
|
35,251
|
|
||
|
Other
|
5,785
|
|
|
5,622
|
|
||
|
Net sales
|
$
|
203,828
|
|
|
$
|
160,566
|
|
|
|
|
|
|
||||
|
Operating income
|
|
|
|
|
|
||
|
Advanced Connectivity Solutions
|
$
|
19,689
|
|
|
$
|
15,900
|
|
|
Elastomeric Material Solutions
|
12,912
|
|
|
5,305
|
|
||
|
Power Electronics Solutions
|
4,935
|
|
|
1,296
|
|
||
|
Other
|
1,905
|
|
|
1,598
|
|
||
|
Operating income
|
39,441
|
|
|
24,099
|
|
||
|
|
|
|
|
||||
|
Equity income in unconsolidated joint ventures
|
1,009
|
|
|
613
|
|
||
|
Other income (expense), net
|
715
|
|
|
(546
|
)
|
||
|
Interest expense, net
|
(1,248
|
)
|
|
(1,121
|
)
|
||
|
Income before income tax expense
|
$
|
39,917
|
|
|
$
|
23,045
|
|
|
Joint Venture
|
Location
|
Reportable Segment
|
Fiscal Year-End
|
|
Rogers INOAC Corporation (RIC)
|
Japan
|
Elastomeric Material Solutions
|
October 31
|
|
Rogers INOAC Suzhou Corporation (RIS)
|
China
|
Elastomeric Material Solutions
|
December 31
|
|
|
Quarter Ended
|
||||||
|
(Dollars in thousands)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
$
|
11,185
|
|
|
$
|
9,237
|
|
|
Gross profit
|
$
|
4,311
|
|
|
$
|
3,099
|
|
|
Net income
|
$
|
2,018
|
|
|
$
|
1,226
|
|
|
(Dollars in thousands)
|
Advanced Connectivity Solutions
|
|
Elastomeric Material Solutions
|
|
Power Electronics Solutions
|
|
Other
|
|
Total
|
||||||||||
|
December 31, 2016
|
$
|
51,693
|
|
|
$
|
91,531
|
|
|
$
|
62,983
|
|
|
$
|
2,224
|
|
|
$
|
208,431
|
|
|
Foreign currency translation adjustment
|
—
|
|
|
1,143
|
|
|
746
|
|
|
—
|
|
|
1,889
|
|
|||||
|
Purchase accounting adjustment
|
—
|
|
|
116
|
|
|
—
|
|
|
—
|
|
|
116
|
|
|||||
|
DSP acquisition
|
—
|
|
|
17,793
|
|
|
—
|
|
|
—
|
|
|
17,793
|
|
|||||
|
March 31, 2017
|
$
|
51,693
|
|
|
$
|
110,583
|
|
|
$
|
63,729
|
|
|
$
|
2,224
|
|
|
$
|
228,229
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
|
(Dollars in thousands)
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
||||||||||||
|
Trademarks and patents
|
$
|
10,177
|
|
|
$
|
1,401
|
|
|
$
|
8,776
|
|
|
$
|
6,825
|
|
|
$
|
1,156
|
|
|
$
|
5,669
|
|
|
Technology
|
71,086
|
|
|
26,217
|
|
|
44,869
|
|
|
68,880
|
|
|
24,365
|
|
|
44,515
|
|
||||||
|
Covenant not to compete
|
1,751
|
|
|
1,009
|
|
|
742
|
|
|
1,419
|
|
|
932
|
|
|
487
|
|
||||||
|
Customer relationships
|
127,102
|
|
|
16,127
|
|
|
110,975
|
|
|
96,148
|
|
|
14,311
|
|
|
81,837
|
|
||||||
|
Total definite lived intangible assets
|
210,116
|
|
|
44,754
|
|
|
165,362
|
|
|
173,272
|
|
|
40,764
|
|
|
132,508
|
|
||||||
|
Indefinite lived intangible assets
|
4,217
|
|
|
—
|
|
|
4,217
|
|
|
4,168
|
|
|
—
|
|
|
4,168
|
|
||||||
|
Total intangible assets
|
$
|
214,333
|
|
|
$
|
44,754
|
|
|
$
|
169,579
|
|
|
$
|
177,440
|
|
|
$
|
40,764
|
|
|
$
|
136,676
|
|
|
Intangible Asset Class
|
|
Weighted Average Amortization Period (Years)
|
|
Trademarks and patents
|
|
7.0
|
|
Technology
|
|
5.8
|
|
Customer relationships
|
|
10.1
|
|
Covenant not to compete
|
|
3.3
|
|
Total definite lived intangible assets
|
|
8.8
|
|
|
Asbestos Claims Activity
|
|
|
Claims outstanding at December 31, 2016
|
605
|
|
|
New claims filed
|
110
|
|
|
Pending claims concluded
|
(123
|
)
|
|
Claims outstanding at March 31, 2017
|
592
|
|
|
(Dollars in thousands)
|
Severance related to headquarters relocation
|
||
|
Balance at December 31, 2016
|
$
|
470
|
|
|
Provisions
|
193
|
|
|
|
Payments
|
(238
|
)
|
|
|
Balance at March 31, 2017
|
$
|
425
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
•
|
failure to capitalize on, or volatility within, the Company’s growth drivers, including connectivity, clean energy, and safety and protection;
|
|
•
|
uncertain business, economic and political conditions in the United States and abroad, particularly in China, South Korea, Germany, Hungary and Belgium, where we maintain significant manufacturing, sales or administrative operations;
|
|
•
|
fluctuations in foreign currency exchange rates;
|
|
•
|
our ability to develop innovative products and have them incorporated into end-user products and systems;
|
|
•
|
the extent to which end-user products and systems incorporating our products achieve commercial success;
|
|
•
|
the ability of our sole or limited source suppliers to deliver certain key raw materials to us in a timely manner;
|
|
•
|
intense global competition affecting both our existing products and products currently under development;
|
|
•
|
failure to realize, or delays in the realization of, anticipated benefits of acquisitions and divestitures due to, among other things, the existence of unknown liabilities or difficulty integrating acquired businesses;
|
|
•
|
our ability to attract and retain management and skilled technical personnel;
|
|
•
|
our ability to protect our proprietary technology from infringement by third parties and/or allegations that our technology infringes third party rights;
|
|
•
|
changes in effective tax rates or tax laws and regulations in the jurisdictions in which we operate;
|
|
•
|
failure to comply with financial and restrictive covenants in our credit agreement or restrictions on our operational and financial flexibility due to such covenants;
|
|
•
|
the outcome of ongoing and future litigation, including our asbestos-related product liability litigation;
|
|
•
|
changes in environmental laws and regulations applicable to our business;
|
|
•
|
disruptions in, or breaches of, our information technology systems;
|
|
•
|
asset impairment and restructuring charges; and
|
|
•
|
changes in accounting standards promulgated by the Financial Accounting Standards Board (FASB) and the Securities and Exchange Commission (SEC).
|
|
•
|
Our net sales increase in the first quarter of 2017 was attributable to increases in net sales of all three of our segments, ACS, EMS and PES.
The EMS segment net sales increased 49.1% due to the DeWAL and DSP acquisitions that occurred in the fourth quarter of 2016 and the first quarter of 2017, respectively, and 16.8% due to increased EMS organic net sales as a result of higher demand in portable electronics, general industrial, automotive and mass transit applications. ACS segment net sales increased on higher demand in automotive and aerospace and defense, partially offset by softening demand in wireless 4G LTE applications. PES saw higher demand for renewable energy, hybrid electric vehicles, variable frequency motor drives, and laser diode coolers. Net sales in the first quarter of 2017 in each of our strategic business segments were negatively impacted by currency fluctuations. See “Segment Sales and Operations.”
|
|
•
|
Our gross margin improved 170 basis points and our operating margin improved 440 basis points in the first quarter of 2017.
Our gross margin improved to 39.4% in the first quarter of 2017 as compared to 37.7% in the first quarter of 2016. Operating income increased to $39.4 million in the first quarter of 2017, as compared to $24.1 million in the first quarter of 2016. Our margins increased as a result of increased demand, capacity utilization, operational process enhancements and automation, conversion of fixed cost structure to variable, benefits from low cost country manufacturing expansion, and synergies from the recent acquisitions.
|
|
•
|
We acquired DeWAL (in late 2016) and DSP (in early 2017), as we continue to execute on our synergistic acquisition strategy.
Acquisitions are a core part of our growth strategy, and these particular acquisitions extend the product portfolio and technology capabilities of our EMS segment, with complementary high-end, high performance elastomeric materials.
|
|
•
|
We are an innovation company, and in the first quarter of 2017 we continued our investment in research and development, with research and development expenses 3.4% of our quarterly net sales.
Research and development (R&D) expenses were $7.0 million in the first quarter of 2017, which is an increase of $0.5 million from the first quarter of 2016. Our spending continues to be focused on developing new platforms and technologies. Since 2013, we have made concerted efforts to realign our R&D organization to better fit the future direction of the Company, including dedicating resources to focus on current product extensions and enhancements to meet our short term technology needs.
|
|
|
Quarter Ended
|
||||
|
|
March 31, 2017
|
|
March 31, 2016
|
||
|
Net sales
|
100.0
|
%
|
|
100.0
|
%
|
|
Gross margin
|
39.4
|
%
|
|
37.7
|
%
|
|
|
|
|
|
||
|
Selling, general and administrative expenses
|
16.8
|
%
|
|
18.6
|
%
|
|
Research and development expenses
|
3.4
|
%
|
|
4.1
|
%
|
|
Restructuring and impairment charges
|
0.4
|
%
|
|
—
|
%
|
|
Gain on sale of long-lived asset
|
(0.5
|
)%
|
|
—
|
%
|
|
Operating income
|
19.4
|
%
|
|
15.0
|
%
|
|
|
|
|
|
||
|
Equity income in unconsolidated joint ventures
|
0.5
|
%
|
|
0.4
|
%
|
|
Other income (expense), net
|
0.4
|
%
|
|
(0.3
|
)%
|
|
Interest expense, net
|
(0.6
|
)%
|
|
(0.7
|
)%
|
|
Income before income tax expense
|
19.6
|
%
|
|
14.4
|
%
|
|
|
|
|
|
||
|
Income tax expense
|
6.3
|
%
|
|
5.1
|
%
|
|
|
|
|
|
||
|
Net income
|
13.3
|
%
|
|
9.3
|
%
|
|
Net Sales
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Net sales
|
|
$
|
203,828
|
|
|
$
|
160,566
|
|
|
26.9%
|
|
Gross margin
|
|
39.4
|
%
|
|
37.7
|
%
|
|
|
||
|
Selling, General and Administrative Expenses
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Selling, general and administrative expenses
|
|
$
|
34,165
|
|
|
$
|
29,860
|
|
|
14.4%
|
|
Percentage of sales
|
|
16.8
|
%
|
|
18.6
|
%
|
|
|
||
|
Research and Development Expenses
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Research and development expenses
|
|
$
|
6,961
|
|
|
$
|
6,549
|
|
|
6.3%
|
|
Percentage of sales
|
|
3.4
|
%
|
|
4.1
|
%
|
|
|
||
|
Other operating expenses (income)
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Restructuring and impairment charges
|
|
$
|
725
|
|
|
$
|
—
|
|
|
100.0%
|
|
Gain on sale of long-lived asset
|
|
(942
|
)
|
|
—
|
|
|
100.0%
|
||
|
Equity Income in Unconsolidated Joint Ventures
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Equity income in unconsolidated joint ventures
|
|
$
|
1,009
|
|
|
$
|
613
|
|
|
64.6%
|
|
Other Income (Expense), Net
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Other income (expense), net
|
|
$
|
715
|
|
|
$
|
(546
|
)
|
|
231.0%
|
|
Interest Expense, Net
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Interest expense, net
|
|
$
|
(1,248
|
)
|
|
$
|
(1,121
|
)
|
|
11.3%
|
|
Income Taxes
|
|
Quarter Ended
|
||||||||
|
(Dollars in thousands)
|
|
March 31, 2017
|
|
March 31, 2016
|
|
Percent Change
|
||||
|
Income tax expense
|
|
$
|
12,885
|
|
|
$
|
8,117
|
|
|
58.7%
|
|
Effective tax rate
|
|
32.3
|
%
|
|
35.2
|
%
|
|
|
||
|
|
Quarter Ended
|
||||||
|
(Dollars in millions)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
$
|
78.5
|
|
|
$
|
73.4
|
|
|
Operating income
|
$
|
19.7
|
|
|
$
|
15.9
|
|
|
|
Quarter Ended
|
||||||
|
(Dollars in millions)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
$
|
76.8
|
|
|
$
|
46.3
|
|
|
Operating income
|
$
|
12.9
|
|
|
$
|
5.3
|
|
|
|
Quarter Ended
|
||||||
|
(Dollars in millions)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
$
|
42.7
|
|
|
$
|
35.3
|
|
|
Operating income
|
$
|
4.9
|
|
|
$
|
1.3
|
|
|
|
Quarter Ended
|
||||||
|
(Dollars in millions)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Net sales
|
$
|
5.8
|
|
|
$
|
5.6
|
|
|
Operating income
|
$
|
1.9
|
|
|
$
|
1.6
|
|
|
(Dollars in thousands
)
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Key Balance Sheet Accounts:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
186,111
|
|
|
$
|
227,767
|
|
|
Accounts receivable, net
|
$
|
134,084
|
|
|
$
|
119,604
|
|
|
Inventories
|
$
|
94,795
|
|
|
$
|
91,130
|
|
|
Outstanding borrowing on credit facilities (short term and long term)
|
$
|
241,188
|
|
|
$
|
241,188
|
|
|
|
Three Months Ended
|
||||||
|
(Dollars in thousands
)
|
March 31, 2017
|
|
March 31, 2016
|
||||
|
Key Cash Flow Measures:
|
|
|
|
|
|
||
|
Cash provided by operating activities
|
$
|
23,234
|
|
|
$
|
26,187
|
|
|
Cash used in investing activities
|
$
|
(63,408
|
)
|
|
$
|
(4,813
|
)
|
|
Cash (used in) provided by financing activities
|
$
|
(2,501
|
)
|
|
$
|
(2,938
|
)
|
|
(Dollars in thousands)
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
U.S.
|
$
|
37,868
|
|
|
$
|
95,481
|
|
|
Europe
|
43,897
|
|
|
37,791
|
|
||
|
Asia
|
104,346
|
|
|
94,495
|
|
||
|
Total cash and cash equivalents
|
$
|
186,111
|
|
|
$
|
227,767
|
|
|
◦
|
Accounts receivable increased
12.1%
to
$134.1 million
as of March 31, 2017, from
$119.6 million
at
December 31, 2016
. The increase from year end was primarily due to higher net sales in the
first
quarter of 2017, in comparison with the fourth quarter of 2016 due to higher net sales in all of our operating segments. Additionally, accounts receivable increased $2.8 million due to the acquisition of DSP in January 2017.
|
|
◦
|
Deferred income tax assets increased
60.4%
to
$23.5 million
as of
March 31, 2017
, from
$14.6 million
at
December 31, 2016
. The increase is due to the recognition of
$12.7 million
in deferred tax assets previously not recognized in accordance with the adoption of new accounting guidance.
|
|
◦
|
Goodwill increased
9.5%
to
$228.2 million
as of
March 31, 2017
, from
$208.4 million
at
December 31, 2016
. the increase is primarily due to the acquisition of DSP in January 2017.
|
|
◦
|
Other intangible assets increased
24.1%
to
$169.6 million
as of March 31, 2017, from
$136.7 million
at
December 31, 2016
. This overall increase is due to the acquisition of DSP in January 2017.
|
|
◦
|
Accrued employee benefits and compensation decreased
20.6%
to
$24.7 million
as of
March 31, 2017
, from
$31.1 million
at
December 31, 2016
. This is primarily due to incentive compensation payouts of $9.0 million that occurred in the first quarter of 2017, partially offset by $3.2 million of accruals for projected incentive compensation payouts for the current performance year.
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 1.
|
Legal Proceedings
|
|
List of Exhibits:
|
|
|
|
|
|
3.1
|
Restated Articles of Organization of Rogers Corporation, as amended, incorporated by reference to Exhibit 3a to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006 (the 2006 Form 10-K) (File No. 001-04347).
|
|
|
|
|
3.2
|
Amended and Restated Bylaws of Rogers Corporation, effective February 11, 2016, incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 26, 2016.
|
|
|
|
|
10.1
|
Third Amended and Restated Credit Agreement, dated as of February 17, 2017 among Rogers Corporation, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, HSBC Bank USA, National Association and Citizens Bank, N.A. as co-syndication agents, and Citibank, N.A. as documentation agent, incorporated by reference to Exhibit 10.24 to the Registrant’s Annual Report on Form 10-K filed February 21, 2017.
|
|
|
|
|
31.1
|
Certification of President and Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
|
|
|
|
|
31.2
|
Certification of Vice President, Finance and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
|
|
|
|
|
32
|
Certification of President and Chief Executive Officer (Principal Executive Officer) and Vice President, Finance and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.
|
|
|
|
|
101
|
The following materials from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2017 formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended March 31, 2017 and March 31, 2016, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2017 and March 31, 2016, (iii) Condensed Consolidated Statements of Financial Position at March 31, 2017 and December 31, 2016, (iv) Condensed Consolidated Statement of Shareholders’ Equity at March 31, 2017 and December 31, 2016, (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2017 and March 31, 2016 and (vi) Notes to Condensed Consolidated Financial Statements.
|
|
ROGERS CORPORATION
(Registrant)
|
|
/s/ Janice E. Stipp
|
|
|
|
Janice E. Stipp
Senior Vice President, Finance and Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
|
|
|
|
|
|
|
|
Dated: May 1, 2017
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|